Multiple Sclerosis Functional Composite

DIAGNOSTIC_TEST2 trials

Sponsors

Transparency Life Sciences, Rennes University Hospital

Conditions

Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive

Phase 2

Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

Transparency Life SciencesMultiple Sclerosis, Relapsing-Remitting

Start: 2014-11-30Target: 20Updated: 2017-10-12

Unknown Phase

Motor Asymmetry in Progressive Multiple Sclerosis Patients

CompletedNCT04918225

Rennes University HospitalMultiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive

Start: 2021-11-03End: 2026-02-10Updated: 2026-03-19